Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jublia with Nail Polish for Onychomycosis
NCT03110029Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Sep 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of efinaconazole in onychomycosis (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoint: Percentage of Nail Polish Disruption Using the Likert Scale at 52 weeks. Started Sep 2015; status: completed.
02
Drugs
efinaconazole
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT03110029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03110029.